Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Anemia, Refractory, with Excess of Blasts × X-Rays × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 5 Wilms Tumor 4 Rhabdoid Tumor 4 Neuroectodermal Tumors, Primitive, Peripheral 4 Neuroblastoma 4 Medulloblastoma 4 Histiocytosis, Langerhans-Cell 4 Hepatoblastoma 4 Glioma 4 Ependymoma 4 Sarcoma 3 Rhabdomyosarcoma 3 Osteosarcoma 3 Lung Neoplasms 3 Central Nervous System Neoplasms 3 Breast Neoplasms 3 Sarcoma, Ewing 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroendocrine Tumors 2 Malignant Solid Neoplasm 2 Lymphoma 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Thyroid Neoplasms 1 Thrombosis 1 Prostatic Neoplasms 1

Interventions

Mycophenolic Acid 19 Whole-Body Irradiation 18 Cyclophosphamide 17 fludarabine phosphate 16 Cyclosporine 13 Tacrolimus 11 Busulfan 11 fludarabine 9 Peripheral Blood Stem Cell Transplantation 9 Cord Blood Stem Cell Transplantation 8 Melphalan 7 Granulocyte Colony-Stimulating Factor 7 Cytarabine 7 Filgrastim 6 Antilymphocyte Serum 6 Methotrexate 5 Etoposide 5 Azacitidine 4 Vorinostat 3 Thiotepa 3 Sirolimus 3 Radiotherapy 3 Idarubicin 3 Cyclosporins 3 tipifarnib 2 thymoglobulin 2 merphos 2 Lenalidomide 2 Flow Cytometry 2 Decitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡